Company Information
Company Profile
Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. Enveric is committed to developing novel treatments to transform the lives of patients living with mental illness. We are pursuing new pathways and targeting impaired neural circuitry with the goal of improving brain health. Our mission is to pioneer new and innovative solutions with the potential to have profound effects on patients and their families, and to deliver life-changing medicines for diseases affecting the brain. Enveric is headquartered in Naples, FL with offices in Cambridge, MA and Calgary, AB Canada.
Leadership
IR Contacts
Investor Relations
Tiberend Strategic Advisors
Daniel Kontoh-Boateng
dboateng@tiberend.com
(862) 213-1398
Jonathan Nugent
jnugent@tiberend.com
(205) 566-3026
Media
Tiberend Strategic Advisors
Casey McDonald
cmcdonald@tiberend.com
(646) 577-8520
Dave Schemelia
dschemelia@tiberend.com
(609) 468-9325
Auditor
Friedman LLP
100 Eagle Rock Avenue, Suite 200
East Hanover, NJ 07936
(973) 929-3500
Transfer Agent
American Stock Transfer and Trust Co.
help@astfinancial.com
(800) 937-5449
U.S. Legal Council
Haynes and Boone, LLP
30 Rockefeller Plaza, 26th Floor
New York, NY 10112
(212) 659-7300
Frequently Asked Questions
What is Enveric Biosciences?
Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders.
What year was Enveric Biosciences founded?
Enveric Biosciences was incorporated in the state of Delaware on January 11, 2018 and completed its organization, formation, and initial capitalization activities effective as of June 7, 2018
Where is Enveric Biosciences headquartered?
4851 Tamiami Trail N, Suite 200, Naples, FL 34103
What are Enveric Biosciences industry classifications?
Sector: Biotechnology
SIC: 2834 – Pharmaceutical Preparations
When did Enveric Biosciences go public?
Enveric Biosciences became a publicly traded company through a tender offer and reverse capitalization on December 23, 2020.
How do I invest in Enveric Biosciences?
You can purchase shares in the Company through a registered broker-dealer of your choice. You cannot purchase units directly from the Company. For information about investing in stocks, you may want to consult a financial professional to explain to you the risks and suitability when investing.
Does Enveric Biosciences offer a Direct Stock Purchase Plan (DSPP or DRIP)?
We do not offer a direct stock purchase or dividend reinvestment program.
Does Enveric Biosciences pay a dividend?
Enveric Biosciences does not anticipate paying any cash dividends in the foreseeable future.
When is Enveric Biosciences’ fiscal year end?
December 31
Who is Enveric Biosciences’ outside legal counsel?
Haynes and Boone LLP
Who is Enveric Biosciences’ transfer agent?
American Stock Transfer and Trust Co. can be reached by email at help@astfinancial.com or by telephone at (800) 937-5449.
Where do I find SEC filings?
You can go to the official SEC website or you can view them in the Investors section of this website.
